BioSpace News Archive

- Company Expects to Report Top-line Data in Mid-2019 and is Building the Commercial Capabilities to Support the Planned Launch of DCC-2618 in the United States -

Brooks Automation, Inc. announced today that it has closed its previously announced acquisition of GENEWIZ Group.

BioSpecifics Technologies Corp. today announced that Ron Law, Ph.D., J.D. has been appointed as Senior Vice President of Business Development and will be responsible for strategic partnerships, reporting directly to Thomas L. Wegman, President of BioSpecifics. Dr. Law has been consulting for BioSpecifics since July 15, 2018.

Recommendation based on results from the Phase 3 CheckMate -214 clinical trial

The Government of Canada, Government of Alberta and First Nations partners are working together to ensure that First Nations children in Alberta can access the supports and services they need, when they need them.

Immediate Availability of 10mg per 10mL Vial of Generic Arsenic Trioxide for Intravenous Use

Endologix, Inc. today honored four innovators of aortic therapy at the 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium®), a meeting of endovascular specialists highlighting developments in the treatment of vascular disease.

Adrian Adams To Serve as Independent Chairperson of the Board After Merger

Thermi®, an Almirall, S.A. company, today announced that it has received a notice of completion to a U.S. Food and Drug Administration (FDA) inquiry on products used in “vaginal rejuvenation” procedures.

The Guardian Life Insurance Company of America (Guardian®), a leading national provider of life and disability insurance, employee benefits, and dental insurance, today announced its Board of Directors approved a $978 million dividend allocation to its individual life policyholders in 2019.